Company Filing History:
Years Active: 2018
Title: Kim Ewing Melville Agnew: Innovator in Monensin Granule Formulation
Introduction
Kim Ewing Melville Agnew is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of water dispersible granules.
Latest Patents
Agnew holds a patent for "Monensin water dispersible granules by wet granulation." This innovative formulation comprises from about 5% to about 80% (w/w) of monensin, along with surfactants, binders, fillers, and water. The patent also details a process for preparing this granule formulation and a method for administering it to animals effectively.
Career Highlights
Agnew is currently associated with Elanco US Inc., where he continues to work on advancements in pharmaceutical formulations. His expertise in the field has led to the successful development of products that enhance the delivery of therapeutics.
Collaborations
Throughout his career, Agnew has collaborated with notable colleagues, including Constantine Paul Benikos and William Austin Hewitt. These partnerships have contributed to the innovative work being done at Elanco.
Conclusion
Kim Ewing Melville Agnew is a distinguished inventor whose work in monensin granule formulation has the potential to impact animal health significantly. His contributions to the field exemplify the importance of innovation in pharmaceutical sciences.